161 related articles for article (PubMed ID: 9808564)
1. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.
Healey JF; Barrow RT; Tamim HM; Lubin IM; Shima M; Scandella D; Lollar P
Blood; 1998 Nov; 92(10):3701-9. PubMed ID: 9808564
[TBL] [Abstract][Full Text] [Related]
2. Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII.
Healey JF; Lubin IM; Nakai H; Saenko EL; Hoyer LW; Scandella D; Lollar P
J Biol Chem; 1995 Jun; 270(24):14505-9. PubMed ID: 7540171
[TBL] [Abstract][Full Text] [Related]
3. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
[TBL] [Abstract][Full Text] [Related]
4. Elimination of a major inhibitor epitope in factor VIII.
Lubin IM; Healey JF; Scandella D; Runge MS; Lollar P
J Biol Chem; 1994 Mar; 269(12):8639-41. PubMed ID: 7510693
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
Barrow RT; Healey JF; Jacquemin MG; Saint-Remy JM; Lollar P
Blood; 2001 Jan; 97(1):169-74. PubMed ID: 11133757
[TBL] [Abstract][Full Text] [Related]
6. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
[TBL] [Abstract][Full Text] [Related]
7. Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes.
Walter JD; Werther RA; Brison CM; Cragerud RK; Healey JF; Meeks SL; Lollar P; Spiegel PC
Blood; 2013 Dec; 122(26):4270-8. PubMed ID: 24085769
[TBL] [Abstract][Full Text] [Related]
8. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII.
Lollar P
Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232
[TBL] [Abstract][Full Text] [Related]
9. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.
Pratt KP; Qian J; Ellaban E; Okita DK; Diethelm-Okita BM; Conti-Fine B; Scott DW
Thromb Haemost; 2004 Sep; 92(3):522-8. PubMed ID: 15351848
[TBL] [Abstract][Full Text] [Related]
10. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.
Barrow RT; Healey JF; Gailani D; Scandella D; Lollar P
Blood; 2000 Jan; 95(2):564-8. PubMed ID: 10627463
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope.
Parker ET; Healey JF; Barrow RT; Craddock HN; Lollar P
Blood; 2004 Aug; 104(3):704-10. PubMed ID: 15073030
[TBL] [Abstract][Full Text] [Related]
12. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
[TBL] [Abstract][Full Text] [Related]
13. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
[TBL] [Abstract][Full Text] [Related]
14. Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation.
Meeks SL; Healey JF; Parker ET; Barrow RT; Lollar P
Blood; 2007 Dec; 110(13):4234-42. PubMed ID: 17848617
[TBL] [Abstract][Full Text] [Related]
15. Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII.
van den Brink EN; Bril WS; Turenhout EA; Zuurveld M; Bovenschen N; Peters M; Yee TT; Mertens K; Lewis DA; Ortel TL; Lollar P; Scandella D; Voorberg J
Blood; 2002 Apr; 99(8):2828-34. PubMed ID: 11929772
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the human factor VIII A2 inhibitor epitope by alanine scanning mutagenesis.
Lubin IM; Healey JF; Barrow RT; Scandella D; Lollar P
J Biol Chem; 1997 Nov; 272(48):30191-5. PubMed ID: 9374501
[TBL] [Abstract][Full Text] [Related]
17. The 1.7 Å X-ray crystal structure of the porcine factor VIII C2 domain and binding analysis to anti-human C2 domain antibodies and phospholipid surfaces.
Brison CM; Mullen SM; Wuerth ME; Podolsky K; Cook M; Herman JA; Walter JD; Meeks SL; Spiegel PC
PLoS One; 2015; 10(3):e0122447. PubMed ID: 25775247
[TBL] [Abstract][Full Text] [Related]
18. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
Yada K; Nogami K; Shima M
Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
[TBL] [Abstract][Full Text] [Related]
19. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
[TBL] [Abstract][Full Text] [Related]
20. A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor.
Jacquemin M; Benhida A; Peerlinck K; Desqueper B; Vander Elst L; Lavend'homme R; d'Oiron R; Schwaab R; Bakkus M; Thielemans K; Gilles JG; Vermylen J; Saint-Remy JM
Blood; 2000 Jan; 95(1):156-63. PubMed ID: 10607698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
